Protocol # EFC10531: A Multi-Center Double-Blind Parallel-Group Placebo-Controlled Study of the Efficacy and Safety of teriflunomide in Patients with Relapsing Multiple Sclerosis
|Effective start/end date||1/1/09 → 12/31/13|
- SANOFI-AVENTIS US
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.